A detailed history of Wolverine Asset Management LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Wolverine Asset Management LLC holds 155,458 shares of BHC stock, worth $1.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
155,458
Previous 155,458 -0.0%
Holding current value
$1.15 Million
Previous $1.08 Million 16.9%
% of portfolio
0.03%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

BUY
$21.6 - $27.79 $368,344 - $473,902
17,053 Added 12.32%
155,458 $3.55 Million
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $107,346 - $128,867
-4,287 Reduced 3.0%
138,405 $3.85 Million
Q2 2021

Aug 13, 2021

BUY
$27.43 - $32.7 $3.46 Million - $4.13 Million
126,200 Added 765.22%
142,692 $4.18 Million
Q1 2021

May 13, 2021

SELL
$21.37 - $34.38 $232,890 - $374,673
-10,898 Reduced 39.79%
16,492 $523,000
Q4 2020

Feb 12, 2021

SELL
$15.31 - $21.12 $304,546 - $420,119
-19,892 Reduced 42.07%
27,390 $569,000
Q3 2020

Nov 13, 2020

BUY
$14.88 - $20.13 $432,859 - $585,581
29,090 Added 159.91%
47,282 $734,000
Q1 2020

May 13, 2020

BUY
$12.98 - $30.25 $32,462 - $75,655
2,501 Added 15.94%
18,192 $281,000
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $459,360 - $564,520
-22,000 Reduced 58.37%
15,691 $342,000
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $65,664 - $84,640
-3,200 Reduced 7.83%
37,691 $950,000
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $8.39 Million - $10.9 Million
-414,755 Reduced 91.03%
40,891 $1.01 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $9.4 Million - $11.7 Million
455,646 New
455,646 $11.7 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.